Lexicon Pharmaceuticals I...

NASDAQ: LXRX · Real-Time Price · USD
1.24
0.06 (5.08%)
At close: Aug 15, 2025, 3:59 PM
1.23
-0.40%
After-hours: Aug 15, 2025, 07:58 PM EDT

Lexicon Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
3.25M -25.3M -33.77M -64.81M -53.43M -48.4M -48.24M -50.52M -44.9M -31.93M -30.49M -23.39M -24.59M -23.48M -25.61M -23.12M -18.07M -20.96M
Depreciation & Amortization
176K 176K 125K 126K 139K 144K 147K 151K 144K 112K 103K 108K 107K 109K 112K 101K 42K 37K
Stock-Based Compensation
3.19M 3.04M 1.54M 2.8M 4.86M 4.3M 3.21M 3.9M 3.81M 3.42M 3.27M 2.65M 2.83M 2.77M 2.23M 2.71M 2.79M 2.85M
Other Working Capital
n/a 1.4M 2.81M -1.32M -495K -1.71M -886K 1.54M -2.62M 3M 481K 171K -792K 480K 386K 89.76M 90.44M 106.42M
Other Non-Cash Items
10.37M -2.46M -1.16M 1.04M -4.36M 291K 5.51M -3M 273K 265K 348K 217K 154K 25K 8K 17K 15K 14K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -6.9M n/a n/a n/a n/a n/a n/a n/a 49K n/a n/a n/a
Change in Working Capital
n/a -19.24M 11.77M 7.22M 4.25M -11.47M -4.28M 7.85M 2.56M -3.47M 5.21M 975K -2.93M -2.85M 386K 3.14M -6.66M -7.1M
Operating Cash Flow
16.99M -43.78M -21.49M -53.62M -48.54M -55.13M -50.55M -41.62M -38.12M -31.61M -21.57M -19.44M -24.42M -23.42M -22.83M -17.15M -21.88M -25.16M
Capital Expenditures
n/a n/a -474K -307K -250K n/a n/a -83K -139K -248K -1.25M -4K n/a -76K -23K -213K -947K -38K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -101.37M 39.24M 74.47M -12.34M -25.42M 77.19M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-27.19M -66.3M -25.83M -50.04M -77.07M -183.22M -102K -72.24M -122.13M -28.86M -586K -93.19M -22.36M -17.82M -5.38M -4.51M -2.69M -21.69M
Sales Maturities Of Investments
41.45M 105.55M 80M 96.4M 65M 73M 52M 33M 47.66M 41.2M 26.01M 16M 8.71M 13.48M 11.5M 4.32M 17.77M 4M
Other Investing Acitivies
1.21M 1.33M n/a 7.42M n/a -110.22M 51.9M -39.24M -74.47M 12.34M 25.42M -77.19M -13.65M -4.33M 6.12M -187K 15.09M -17.69M
Investing Cash Flow
15.48M 40.58M 53.7M 53.47M -12.32M -110.22M 51.9M -39.33M -74.61M 12.09M 24.17M -77.2M -13.65M -4.41M 6.1M -400K 14.14M -17.72M
Debt Repayment
n/a n/a n/a n/a n/a n/a -1K 1K 49.96M n/a 24.97M -249K n/a 24.15M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a -1.73M 211K n/a n/a -824K n/a n/a n/a -864K n/a n/a n/a -2.67M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-45M -572K 63K -916K -14K -400K n/a n/a 139.03M n/a n/a 94.27M -6.32M n/a -11.7M n/a n/a n/a
Financial Cash Flow
-45M -572K -104K -916K -14K 239.38M -1K -210K 189M -824K 24.91M 94.02M n/a 23.28M -11.32M 19.78M -23K 14.27M
Net Cash Flow
-12.52M -3.77M 32.1M -1.07M -60.88M 74.03M 1.35M -81.16M 76.27M -20.34M 27.51M -2.62M -38.07M -4.54M -28.05M 2.23M -7.76M -28.61M
Free Cash Flow
16.99M -43.78M -21.96M -53.93M -48.79M -55.13M -50.55M -41.7M -38.26M -31.86M -22.82M -19.44M -24.42M -23.5M -22.85M -17.36M -22.83M -25.2M